<![CDATA[BIOVIC - Novel breast cancer test is reporting tomorrow]]>Biovica Int (BIOVIC), Sweden based novel breast cancer test company is reporting tomorrow.

BIOVIC is down 50% due to delay of FDA approval due to FDA covid congestion. The thesis is unchanged. FDA covid related delay should not change the valuation.

Link Preview Image
Biovica – our doubling candidate is reporting tomorrow

I have been long Biovica (BIOVIC) for some time. The thesis has been delayed by the FDA approval delay due to FDA Covid congestion. Many retail investors lost patience. The stock is down, but the thesis is unchanged. One or two months delay should not affect the value of the company. FDA Covid-caused FDA congestion…

favicon

Fit Investment Ideas (fitinvestmentideas.com)

]]>https://dev.proinvestor.com/forum/topic/443384/biovic-novel-breast-cancer-test-is-reporting-tomorrowRSS for NodeFri, 03 Jul 2026 10:59:11 GMTTue, 30 Nov 2021 14:07:54 GMT60<![CDATA[Reply to BIOVIC - Novel breast cancer test is reporting tomorrow on Wed, 01 Dec 2021 05:53:45 GMT]]>Biovica FDA udmelding udsat til ultimo 21 grundet travlhed.

]]>https://dev.proinvestor.com/forum/post/9471882https://dev.proinvestor.com/forum/post/9471882Wed, 01 Dec 2021 05:53:45 GMT<![CDATA[Reply to BIOVIC - Novel breast cancer test is reporting tomorrow on Tue, 30 Nov 2021 15:00:06 GMT]]>God tekst at læse når man har en pæn stak, ikke mindst linjen under overskriften. Nå, seriøst er det en af de mere sikre bioteks. Belønningen er nu ikke længere ude i kimningen, men lige ude over rælingen:-)

]]>https://dev.proinvestor.com/forum/post/9471885https://dev.proinvestor.com/forum/post/9471885Tue, 30 Nov 2021 15:00:06 GMT